Published in Blood Weekly, October 9th, 2003
The findings support thinking that physicians may optimize care by adjusting treatment according to a patient's specific genetic condition. The findings were presented at the American Association for Cancer Research (AACR)-sponsored specialty meeting on "SNPs, Haplotype, and Cancer: Application in Molecular Epidemiology."
Although chemotherapy drugs can be effective against myeloma in many patients, they can be less effective or even lethal in others. By...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.